DA 2020, Sch. 2, para. 69

In forcesince 14 Jul 2020

An offence under any of the following provisions of the Human Medicines Regulations 2012—

(a)

regulation 34(1) (offences: breach of regulations and false information and defence concerning starting materials),

(b)

regulation 255(1)(a), (b), (c) or (d) (offences relating to dealings with medicinal products).